Le, T.B.U.; Vu, T.C.; Ho, R.Z.W.; Prawira, A.; Wang, L.; Goh, B.C.; Huynh, H.
Bevacizumab Augments the Antitumor Efficacy of Infigratinib in Hepatocellular Carcinoma. Int. J. Mol. Sci. 2020, 21, 9405.
https://doi.org/10.3390/ijms21249405
AMA Style
Le TBU, Vu TC, Ho RZW, Prawira A, Wang L, Goh BC, Huynh H.
Bevacizumab Augments the Antitumor Efficacy of Infigratinib in Hepatocellular Carcinoma. International Journal of Molecular Sciences. 2020; 21(24):9405.
https://doi.org/10.3390/ijms21249405
Chicago/Turabian Style
Le, Thi Bich Uyen, Thanh Chung Vu, Rebecca Zhi Wen Ho, Aldo Prawira, Lingzhi Wang, Boon Cher Goh, and Hung Huynh.
2020. "Bevacizumab Augments the Antitumor Efficacy of Infigratinib in Hepatocellular Carcinoma" International Journal of Molecular Sciences 21, no. 24: 9405.
https://doi.org/10.3390/ijms21249405
APA Style
Le, T. B. U., Vu, T. C., Ho, R. Z. W., Prawira, A., Wang, L., Goh, B. C., & Huynh, H.
(2020). Bevacizumab Augments the Antitumor Efficacy of Infigratinib in Hepatocellular Carcinoma. International Journal of Molecular Sciences, 21(24), 9405.
https://doi.org/10.3390/ijms21249405